PTC Therapeutics Inc (NAS:PTCT)
$ 36.53 3.23 (9.7%) Market Cap: 2.80 Bil Enterprise Value: 2.34 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 74/100

PTC Therapeutics Inc Corporate Call - PTC299 for the Potential Treatment of COVID-19 Transcript

Jun 17, 2020 / 12:30PM GMT
Release Date Price: $50.34 (-0.50%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the conference call to discuss PTC299 for the potential treatment of COVID-19. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Alex Kane, Executive Director of Investor Relations. Thank you. Please go ahead, sir.

Alex Kane
PTC Therapeutics, Inc. - IR Officer

Thank you, and good morning to everyone joining us. Welcome to the PTC Therapeutics conference call to discuss PTC299 for the potential treatment of COVID-19. Joining me on today's call is our Chief Executive Officer, Stuart Peltz. In conjunction with today's call and webcast, we have posted slides that will be referenced throughout the call, which can be found on the Events & Presentations page under the Investor Relations section of PTC Therapeutics website at www.ptcbio.com.

Before we start, let me remind you that today's call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot